tiprankstipranks
Trending News
More News >
Ryvu Therapeutics SA (PL:RVU)
:RVU
Poland Market

Ryvu Therapeutics SA (RVU) Income Statement

Compare
0 Followers

Ryvu Therapeutics SA Income Statement

Last quarter (Q4 2025), Ryvu Therapeutics SA's total revenue was zł18.00M, a decrease of -29.54% from the same quarter last year. In Q4, Ryvu Therapeutics SA's net income was zł-17.59M. See Ryvu Therapeutics SA’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
zł 62.25Mzł 77.97Mzł 46.86Mzł 38.80Mzł 11.19M
Gross Profit
zł -117.03Mzł 58.39Mzł 29.31Mzł 21.40Mzł -2.54M
Operating Expenses
zł 5.12Mzł 180.49Mzł 130.25Mzł 93.07Mzł 75.98M
Depreciation and Amortization
zł 9.44Mzł 10.50Mzł 10.97Mzł 12.90Mzł 12.56M
EBITDA
zł -112.71Mzł -96.83Mzł -81.04Mzł -65.21Mzł -65.96M
Operating Income
zł -122.15Mzł -122.10Mzł -100.95Mzł -78.42Mzł -103.78M
Other Income/Expenses
zł 21.01Mzł 10.96Mzł 8.84Mzł -773.00Kzł -363.00K
Pretax Income
zł -101.14Mzł -111.14Mzł -92.11Mzł -79.19Mzł -78.96M
Net Income
zł -101.23Mzł -111.44Mzł -92.11Mzł -83.78Mzł -79.08M
Per Share Metrics
Basic EPS
zł -4.38zł -4.82zł -4.02zł -4.57zł -4.31
Diluted EPS
zł -4.38zł -4.82zł -4.02zł -4.57zł -4.31
Weighted Average Shares Outstanding
23.12M 23.12M 22.90M 18.33M 18.36M
Weighted Average Shares Outstanding (Diluted)
23.12M 23.12M 22.90M 18.33M 18.36M
Currency in PLN

Ryvu Therapeutics SA Earnings and Revenue History